Smoking has emerged as a significant modifiable risk factor for cholangiocarcinoma. Research has shown a strong association between smoking and the development of Bile Duct Cancer. The harmful chemicals present in tobacco smoke can damage the bile ducts, leading to cellular changes and increased cancer risk. Studies have highlighted that smokers are at a higher risk of developing cholangiocarcinoma compared to non-smokers.
Smoking can worsen the prognosis for individuals diagnosed with Bile Duct Cancer, as it can promote tumor growth, metastasis, and treatment resistance. Quitting smoking can significantly reduce the risk of developing cholangiocarcinoma and improve overall health outcomes. Healthcare professionals play a crucial role in raising awareness about the detrimental effects of smoking on cholangiocarcinoma risk and providing smoking cessation support to individuals at risk or diagnosed with cholangiocarcinoma.